| |
| |
|
| Insider
Information: |
Fuhrman Alan |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
43,371 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$57,768 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
43,371 |
|
|
| Total
Value |
$57,768 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
Director |
2018-06-08 |
0 |
2018-06-08 |
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
30,404 |
|
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director |
2023-05-24 |
10,572 |
2021-05-20 |
0 |
Premium* |
|
|
Tyra Biosciences, Inc. |
TYRA |
|
2024-03-15 |
2,395 |
2023-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TYRA |
Tyra Biosciences, Inc. |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
A |
$12.48 |
$11,629 |
D/D |
932 |
2,395 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-09-15 |
4 |
A |
$12.50 |
$18,293 |
D/D |
1,463 |
1,463 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
30,404 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,648 |
10,572 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,818 |
5,924 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,376 |
25,254 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,106 |
25,227 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,221 |
12,878 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,003 |
11,657 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2020-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
654 |
|
% |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2018-06-08 |
4 |
S |
$178.07 |
$467,437 |
D/D |
(2,625) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2018-06-08 |
4 |
OE |
$11.35 |
$29,794 |
D/D |
2,625 |
2,625 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
